3-Year Interim Safety Profile of Adeno-Associated Virus Serotype 2-soluble Variant of the Vascular Endothelial Growth Factor Receptor Type 1 (AAV2-sFLT01) Administered by Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration

著录项

• 来源
  《Investigative ophthalmology & visual science》 |2017年第8期|共3页
• 作者

  Varona Rafael; Le-Halpere Annaig; Campochiaro Peter A.; Heier Jeffrey; Dugel Pravin U.; Barsamian Mark; Purvis Annie; Cabrera-Salazar Mario; Delacono Cheryl; Mostafa Najwa; Scaria Abraham; Buggage Ronald;

  展开▼
• 作者单位

  Sanofi R&

  D Chilly Mazarin France;

  Sanofi R&

  D Chilly Mazarin France;

  Johns Hopkins Wilmer Eye Inst Baltimore MD USA;

  Ophthalm Consultants Boston Boston MA USA;

  Retinal Consultants Arizona Phoenix AZ USA;

  UMass Mem Med Ctr Hyannis MA USA;

  Sanofi R&

  D US Cambridge MA USA;

  Sanofi R&

  D US Cambridge MA USA;

  Sanofi R&

  D US Cambridge MA USA;

  Sanofi R&

  D US Cambridge MA USA;

  Sanofi R&

  D US Cambridge MA USA;

  Sanofi R&

  D Chilly Mazarin France;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 眼科学;
• 关键词